EUVIMEDEUVIMED entdecken
Crossref

Efficacy of intravitreal bevacizumab monotherapy in the treatment of retinopathy of prematurity

Caner KARA, Ikbal Seza PETRICLI, Aysegul ARMAN, Cagatay OZCAN, Fatma IYIGUN

Journal of Retina-Vitreous · 2020

DOI: 10.37845/ret.vit.2020.29.36 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Retina-Vitreous, 2020. Verfasst von Caner KARA und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

KARA, C., PETRICLI, I. S., ARMAN, A., OZCAN, C., & IYIGUN, F. (2020). Efficacy of intravitreal bevacizumab monotherapy in the treatment of retinopathy of prematurity. Journal of Retina-Vitreous. https://doi.org/10.37845/ret.vit.2020.29.36

Vancouver

KARA C, PETRICLI IS, ARMAN A, OZCAN C, IYIGUN F. Efficacy of intravitreal bevacizumab monotherapy in the treatment of retinopathy of prematurity. Journal of Retina-Vitreous. 2020. doi:10.37845/ret.vit.2020.29.36

BibTeX
@article{KARA2020,
  author = {KARA, Caner and PETRICLI, Ikbal Seza and ARMAN, Aysegul and OZCAN, Cagatay and IYIGUN, Fatma},
  title = {Efficacy of intravitreal bevacizumab monotherapy in the treatment of retinopathy of prematurity},
  journal = {Journal of Retina-Vitreous},
  year = {2020},
  doi = {10.37845/ret.vit.2020.29.36}
}
Kostenlos starten →